BioPharma Credit PLC (LON:BPCP – Get Free Report)’s stock price reached a new 52-week high on Thursday . The company traded as high as GBX 70.90 and last traded at GBX 70.90, with a volume of 357588 shares changing hands. The stock had previously closed at GBX 67.90.
BioPharma Credit Stock Performance
The firm’s 50 day moving average is GBX 67.79 and its 200 day moving average is GBX 67.65. The stock has a market cap of £964.53 million, a P/E ratio of 10.37 and a beta of 0.22.
About BioPharma Credit
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
Further Reading
- Five stocks we like better than BioPharma Credit
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Trump’s AI Secret: 100X Faster Than Nvidia
- Your Bank Account Is No Longer Safe
- Trump Planning to Use Public Law 63-43: Prepare Now
- Buy This Stock Now
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
